Merck 2nd Quarter Tops Street View on Strong Keytruda Sales
July 30 Reuters Merck Co posted higherthanexpected secondquarter results on Tuesday on strong growth of its blockbuster cancer immunotherapy Keytruda, the world39;s bestselling prescription medicine. New Jerseybased Merck slightly raised its fullyear sales projections, following other big pharmaceutical companies like Roche, Johnson Johnson and Bristol Myers Squibb, which lifted their forecasts when they reported earnings earlier this month. Merck posted a […]